CAS 1188264-72-3

Citalopram EP Impurity D HBr (Citalopram USP Related Compound D HBr, N-Desmethyl Citalopram HBr)

CAS : 1188264-72-3

Formule : C₁₉H₁₉FN₂O·HBr

Couleur et forme : White To Off-White Solid

Masse moléculaire : 310.37 80.91

Ref: 4Z-C-095

rac Desmethyl Citalopram Hydrobromide

Produit contrôlé

CAS : 1188264-72-3

Impurity USP Citalopram Related Compound D
Applications rac Desmethyl Citalopram Hydrobromide is a metabolite of Citalopram, an inhibitor of serotonin (5-HT) uptake. Used as an antidepressant.
References Gnerre, C., et al.: J. Pharm. Pharmacol., 53, 1125 (2001), Hagg, S., et al.: Br. J. Clin. Pharmacol., 51, 169 ( 2001), von Moltke, L., et al.: Drug Metab. Dispos., 29, 1102 (2001), Reis, M., et al.: Ther. Drug Monit., 27, 469 (2005),

Formule : C₁₉H₁₉FN₂O·BrH

Couleur et forme : Neat

Masse moléculaire : 391.28

Ref: TR-D230870

rac Desmethyl Citalopram-d4 Hydrobromide

Produit contrôlé

CAS : 1188264-72-3

Applications rac Desmethyl Citalopram-d4 Hydrobromide is the labeled analogue of rac Desmethyl Citalopram Hydrobromide (D230870), a metabolite of Citalopram (C505000), an inhibitor of serotonin (5-HT) uptake. Used as an antidepressant.
References Gnerre, C., et al.: J. Pharm. Pharmacol., 53, 1125 (2001); Hagg, S., et al.: Br. J. Clin. Pharmacol., 51, 169 ( 2001); von Moltke, L., et al.: Drug Metab. Dispos., 29, 1102 (2001); Reis, M., et al.: Ther. Drug Monit., 27, 469 (2005)

Formule : C₁₉H₁₆D₄BrFN₂O

Couleur et forme : Neat

Masse moléculaire : 395.3

Ref: TR-D230872

Citalopram Related Compound D

CAS : 1188264-72-3

Citalopram Related Compound D is an antiepileptic drug that belongs to the group of phenylpiperazine derivatives. It is a prodrug which is metabolized into escitalopram, its active form. Citalopram Related Compound D has been shown to have similar pharmacokinetic properties as escitalopram oxalate, with a half-life of about 3 hours. This drug has been shown to be effective in treating epilepsy and may also be used for the treatment of other neurological disorders such as Parkinson's disease and Alzheimer's disease. Citalopram Related Compound D is not indicated for use in patients who are taking carbamazepine or phenobarbital because it can increase plasma concentrations of these drugs.

Formule : C₁₉H₁₉FN₂O·HBr

Degré de pureté : Min. 95%

Masse moléculaire : 391.28 g/mol

Ref: 3D-NXB26472